Register entry
- Registered sites
- 0
- Active NDC listings
- 3
- Live patents
- 9
- Exclusivities
- 1
- Countries
- 0
Catalogue
Drug listings by form and route
33 active NDC listings: 3 human prescription drug. By marketing category: NDA 3.
| Dosage form | NDCs |
|---|---|
| tablet, film coated | 3 |
| Route | NDCs |
|---|---|
| oral | 3 |
| Labeller name on the listing | NDCs |
|---|---|
| syndax pharmaceuticals, inc. | 3 |
Exclusivity
Patents and exclusivities
9| Patent | Product | Covers | Expiry |
|---|---|---|---|
| 10683302 | REVUFORJrevumenib citrate | substance, product | Jun 2037 |
| 11479557 | REVUFORJrevumenib citrate | product | Jun 2037 |
| 12564590 | REVUFORJrevumenib citrate | product | Dec 2042 |
| Product | Exclusivity | Until |
|---|---|---|
| REVUFORJREVUMENIB CITRATE | ODE-502 Orphan drug | Nov 2031 |
Catalogue
Marketed products
3| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| Revuforj | revumenib | tablet, film coated, oral | 73555-500NDA |
| Revuforj | revumenib | tablet, film coated, oral | 73555-501NDA |
| Revuforj | revumenib | tablet, film coated, oral | 73555-502NDA |
Enquiry
Common questions
- Is Syndax Pharmaceuticals, Inc. FDA approved?
- Syndax Pharmaceuticals, Inc. holds no registered establishment of its own; 3 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does Syndax Pharmaceuticals, Inc. make?
- 3 products are listed under Syndax Pharmaceuticals, Inc. in the openFDA NDC Directory, most often as tablet, film coated. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.